Literature DB >> 8057777

Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies.

A Bal1, T Bachelot, M Savasta, M Manier, J M Verna, A L Benabid, C Feuerstein.   

Abstract

The expression of dopamine D2 receptor mRNA in cultured rat striatal and cerebellar astrocytes was examined by in situ hybridization (ISH) and polymerase chain reaction (PCR). Cells double-labelled for glial fibrillary acidic protein (GFAP) immuno-histochemistry and dopamine D2 receptor mRNA (ISH) provide evidence that striatal but not cerebellar astrocytes express the dopamine D2 gene in vitro. These results were confirmed by polymerase chain reaction studies. As judged by GFAP immunostaining and morphology of the cells, this gene is almost exclusively expressed by astrocytes type 1. The expression of dopamine D2 receptor mRNA by striatal astrocytes in vitro, as found in this study, brings thus evidences for the existence of dopamine D2 receptors in such glial cells. This had been previously suggested from ligand binding studies but the typical dopaminergic nature of the binding to striatal astrocytes was left questionable. Our results with molecular biological techniques thus suggest that striatal dopamine might modulate the functions of striatal astrocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057777     DOI: 10.1016/0169-328x(94)90227-5

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  26 in total

1.  An astroglia-linked dopamine D2-receptor action in prefrontal cortex.

Authors:  Z U Khan; P Koulen; M Rubinstein; D K Grandy; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 2.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

3.  A simple solution for antibody signal enhancement in immunofluorescence and triple immunogold assays.

Authors:  Abraham Rosas-Arellano; Juan B Villalobos-González; Lourdes Palma-Tirado; Felipe A Beltrán; Alfonso Cárabez-Trejo; Fanis Missirlis; Maite A Castro
Journal:  Histochem Cell Biol       Date:  2016-05-17       Impact factor: 4.304

4.  Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.

Authors:  G Gille; K Radad; H Reichmann; W-D Rausch
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 5.  Monoamines in glioblastoma: complex biology with therapeutic potential.

Authors:  Seamus Patrick Caragher; Robert Raymond Hall; Riasat Ahsan; Atique U Ahmed
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

6.  Dopamine denervation of the prefrontal cortex increases expression of the astrocytic glutamate transporter GLT-1.

Authors:  Peter J Vollbrecht; Linda D Simmler; Randy D Blakely; Ariel Y Deutch
Journal:  J Neurochem       Date:  2014-03-18       Impact factor: 5.372

Review 7.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 8.  Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets.

Authors:  Kjell Fuxe; Luigi F Agnati; Manuela Marcoli; Dasiel O Borroto-Escuela
Journal:  Neurochem Res       Date:  2015-04-17       Impact factor: 3.996

9.  Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis.

Authors:  Tina M Calderon; Dionna W Williams; Lillie Lopez; Eliseo A Eugenin; Laura Cheney; Peter J Gaskill; Mike Veenstra; Kathryn Anastos; Susan Morgello; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2017-01-29       Impact factor: 4.147

10.  Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin.

Authors:  Wei Shao; Shu-zhen Zhang; Mi Tang; Xin-hua Zhang; Zheng Zhou; Yan-qing Yin; Qin-bo Zhou; Yuan-yuan Huang; Ying-jun Liu; Eric Wawrousek; Teng Chen; Sheng-bin Li; Ming Xu; Jiang-ning Zhou; Gang Hu; Jia-wei Zhou
Journal:  Nature       Date:  2012-12-16       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.